Minoru Hasegawa
Minoru Hasegawa publishes mostly in Pathology and Forensic Medicine, Epidemiology and Dermatology, on topics such as Systemic Sclerosis and Related Diseases, Inflammatory Myopathies and Dermatomyositis and Autoimmune Bullous Skin Diseases.
- World rank
- #972,991 of 7,710,434 ranked researchers
- Rank in Japan
- #12,927 of 383,136
- Works
- 618
- Citations
- 19k
- Citations per work
- 30.0
What does Minoru Hasegawa research?
Minoru Hasegawa's work is mostly in Medicine (36%), Immunology and Microbiology (7%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else31651.1%
- Health Sciences22236.0%
- Medicine22236.0%
- Life Sciences416.6%
- Physical Sciences396.3%
- Chemistry396.3%
- 1Pathology and Forensic Medicine17% of their works
- 2Epidemiology7% of their works
- 3Dermatology7% of their works
- 4Immunology7% of their works
- 5Organic Chemistry6% of their works
- 6Rheumatology6% of their works
Research topics
- Systemic Sclerosis and Related Diseases
- Inflammatory Myopathies and Dermatomyositis
- Autoimmune Bullous Skin Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Systemic Lupus Erythematosus Research
- Dermatologic Treatments and Research
- Dermatology and Skin Diseases
- Synthesis and Biological Evaluation
Which keywords describe Minoru Hasegawa's research?
The keywords of their largest research topics: Autoantibodies, Treatment, Immunosuppressive Therapy, Fibrosis, Pulmonary Involvement, Systemic Sclerosis, Interstitial Lung Disease and Dermatomyositis.
- Quinoxaline
- Filaggrin
- Hypertrophic Scarring
- Antiphospholipid Syndrome
- Idiopathic Pulmonary Fibrosis
- Pemphigoid
- Dermatomyositis
- Systemic Sclerosis
- Fibrosis
- Treatment
- Autoantibodies
- Immunosuppressive Therapy
- Pulmonary Involvement
- Interstitial Lung Disease
- Inflammatory Myopathies
- Rituximab
- TGF-ß
- Systemic Lupus Erythematosus
- Keloids
- Skin Microbiome
- Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Autoantibodies3554 topics
- Treatment2682 topics
- Immunosuppressive Therapy2522 topics
- Fibrosis2362 topics
- Pulmonary Involvement1981 topic
- Systemic Sclerosis1981 topic
- Interstitial Lung Disease1082 topics
- Dermatomyositis701 topic
- Inflammatory Myopathies701 topic
- Pemphigoid541 topic
- Rituximab541 topic
- Idiopathic Pulmonary Fibrosis381 topic
- TGF-ß381 topic
- Antiphospholipid Syndrome331 topic
- Systemic Lupus Erythematosus331 topic
- Hypertrophic Scarring301 topic
- Keloids301 topic
- Filaggrin281 topic
- Skin Microbiome281 topic
- Quinoxaline261 topic
- Synthesis261 topic
Where does Minoru Hasegawa work?
Minoru Hasegawa's main affiliation in the publication record is Kanazawa University, Japan.
How many publications and citations does Minoru Hasegawa have?
OpenAlex counts 618 works and 18,519 citations for Minoru Hasegawa, an h-index of 75, ranking #972,991 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Minoru Hasegawa
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Minoru Hasegawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.